Brief: Nurosene Health Announces Research Partnership
27/01/2022 13:22
Jan 27 (Reuters) - Nurosene Health Inc MEND.CD :
* NUROSENE ANNOUNCES RESEARCH PARTNERSHIP DESIGNED TO
ACCELERATE
AND IDENTIFY NOVEL DRUG CANDIDATES FOR ITS IP PORTFOLIO
Source text for Eikon: ID:nCNWLjdDWa
Further company coverage: MEND.CD
((Reuters.Briefs@thomsonreuters.com;))
Recent news on NetraMark Holdings
See all newsBrief: Netramark Announces Uplisting To Toronto Stock Exchange
Brief: Netramark Signs Four New Contracts With A Leading Global Pharmaceutical Company To Enhance Clinical Trial Insights
Brief: Asklepion Pharmaceuticals Signs Contract To Utilize Netramark Technology In Phase III Pediatric Cardiac Study
Brief: NetraMark Holdings Signs Contract With AlgoTx To Enhance Clinical Trial Design For ATX01
Brief: Netramark And Worldwide Clinical Trials Announce Agreement To Transform Clinical Trial Design With Ai-Powered Precision